MAPK3 and neoplasm: We found that plx8394 inhibited the expression of Ki67, a tumor proliferation marker, and down-regulated the level of phospho-ERK1/2 significantly in all fibroblastomas while plx4720 had a comparable effect only in V600E-induced fibroblastomas (Figure 3E-F and Figure S4B-C), which supports our opinion.